Advertisement
Cardiothoracic Imaging| Volume 98, P16-21, June 2023

Download started.

Ok

Left atrial appendage filling defects restricted to the early phase of cardiac computed tomography is significantly associated with ischemic stroke

Open AccessPublished:March 16, 2023DOI:https://doi.org/10.1016/j.clinimag.2023.03.008

      Highlights

      • Early filling defect in LAA, age and diabetes are independent risk factors for stroke in AF.
      • AF patients with LAA non-thrombotic filling defects on the early-phase of cardiac CT increased ischemic stroke risk.
      • The occurrence of stroke in patients with filling defect may not be related to LAA morphology.

      Abstract

      Purpose

      To investigate the relationship between filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography (CCT), and ischemic stroke in patients with atrial fibrillation (AF).

      Materials and methods

      A total of 152 patients with non-valvular AF were retrospectively enrolled and divided into two groups according to the stroke history, as confirmed by brain computed tomography (CT) or magnetic resonance imaging (MRI), as the non-stroke group (n = 89) and stroke group (n = 63), respectively. The numbers of patients with filling defects in the early phase of CCT images without thrombi were recorded. Morphological parameters of the LAA were measured for all participants. All patients with early-phase filling defects (n = 44) were assigned to two groups according to ischemic stroke history: the filling defects with stroke group (n = 28) and the filling defects without stroke group (n = 16). The clinical characteristics and LAA morphological parameters were compared.

      Results

      Univariate analysis showed that compared with the non-stroke group,LAA volume index and age were higher in the stroke group, and the ratio of early phase filling defect in LAA, hypertension and diabetes were also higher, in the meanwhile the LVEF and BMI were lower (P < 0.05).After adjusting confounding factors by the multivariate logistic regression analysis, filling defect was significantly related with stroke [odds ratio (OR): 4.339, 95% confidence interval (CI): 1.951–9.653, P = 0.000]. LAA morphological parameters were not significantly different between the filling defects with stroke group and the group without stroke.

      Conclusion

      AF patients with LAA non-thrombotic filling defects in the early-phase of CCT had an increased risk of ischemic stroke compared to those without filling defects. This finding may help to optimize stroke risk stratification in patients with AF.

      Keywords

      1. Introduction

      Atrial fibrillation (AF) is one of the most common arrhythmias occurring worldwide. Stroke is one of the leading causes of functional impairment and increased morbidity and mortality in AF patients.
      • Benjamin E.J.
      • Blaha M.J.
      • Chiuve S.E.
      • Cushman M.
      • Das S.R.
      • Deo R.
      • de Ferranti S.D.
      • Floyd J.
      • Fornage M.
      • Gillespie C.
      • Isasi C.R.
      • Jimenez M.C.
      • Jordan L.C.
      • Judd S.E.
      • Lackland D.
      • Lichtman J.H.
      • Lisabeth L.
      • Liu S.
      • Longenecker C.T.
      • Mackey R.H.
      • Matsushita K.
      • Mozaffarian D.
      • Mussolino M.E.
      • Nasir K.
      • Neumar R.W.
      • Palaniappan L.
      • Pandey D.K.
      • Thiagarajan R.R.
      • Reeves M.J.
      • Ritchey M.
      • Rodriguez C.J.
      • Roth G.A.
      • Rosamond W.D.
      • Sasson C.
      • Towfighi A.
      • Tsao C.W.
      • Turner M.B.
      • Virani S.S.
      • Voeks J.H.
      • Willey J.Z.
      • Wilkins J.T.
      • Wu J.H.
      • Alger H.M.
      • Wong S.S.
      • Muntner P.
      American Heart Association Statistics CStroke Statistics S
      Heart disease and stroke statistics-2017 update: a report from the American Heart Association.
      The prevention of stroke is the primary clinical task and the focus of ongoing research. Active exploration of potential risk factors for stroke, and effective primary prevention for high-risk groups at an early stage are important measures to reduce the occurrence of stroke events. Thus, assessing and monitoring the risk of thromboembolism in patients is crucial.
      Although the CHA2DS2-VASc scoring system is widely used for stroke risk assessment in patients with atrial fibrillation, some patients with a low CHA2DS2-VASc score still suffer from stroke.
      • Van den Ham H.A.
      • Klungel O.H.
      • Singer D.E.
      • Leufkens H.G.
      • van Staa T.P.
      Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a National Primary Care Database.
      Therefore, it is of great clinical significance to evaluate the impact of other factors beyond the CHA2DS2-VASc scoring system on stroke.
      Transient non thrombotic contrast agent filling defects in the LAA during early phase scanning are observed in some patients with AF, and they disappear during delayed phase scanning. The early filling defect represents the state of blood stasis, which may be related to the occurrence of stroke; however, the research on this aspect is still relatively scarce.
      • Inoue T.
      • Suematsu Y.
      Poor enhancement pattern of left atrial appendage in cardiac computed tomography is associated with stroke in persistent atrial fibrillation patients.
      At the same time, there is no in-depth study on the relationship between the occurrence of stroke and the morphological changes of the left atrial appendage in patients with early stage filling defects.
      This study aimed to investigate the relationship between filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography (CCT) and ischemic stroke in patients with AF.

      2. Materials and methods

      2.1 Patients and study design

      A total of 152 patients with non-valvular AF between December 2019 and January 2021 were retrospectively enrolled. All patients with AF were clinically diagnosed by physical examination and electrocardiogram (ECG). The patients underwent computed tomography angiography (CTA) examinations before catheter radio-frequency ablation or left atrial appendage occlusion. The baseline demographics of participants were extracted from the electronic medical records. The inclusion criteria were patients without LAA thrombus, and available brain computed tomography (CT) or magnetic resonance imaging (MRI) data. The exclusion criteria were patients with congenital heart disease, rheumatic heart disease, cardiomyopathy, history of cardiac surgery, radio-frequency ablation and LAA closure, pacemaker implantation, moderate to severe mitral stenosis, severe liver and kidney dysfunction, and malignant tumors. The patients were classified into the previous stroke group (n = 63, 35 males, 54 females, age range 50–87 years, mean age 67.25 ± 8.12 years) and non-stroke group (n = 89, 51males, 38 females, age range 32–86 years, mean age 61.64 ± 11.19 years) according to the previous history of ischemic stroke (confirmed by brain CT or MRI).
      All patients with early phase filling defects (n = 44) were assigned to two groups according to ischemic stroke history: filling defects with stroke group (n = 28, 15 males, 13 females), mean age: 66.7 ± 8.5, ranged from 50 to 87 years old, and filling defects without stroke group (n = 16, 9 males, 7 females), mean age: 61.0 ± 10.3, ranged from 42 to 77 years old. The clinical characteristics and LAA morphological parameters were compared.
      In preparation for radio-frequency ablation or left atrial appendage occlusion, all the participants were treated with an anticoagulant regimen during hospitalization.
      The study was approved by the Ethics Committee of the Second Hospital of Hebei Medical University. Written informed consent was obtained from all the patients.

      2.2 CCT examination

      A Philips 256-slice iCT scanner (Brilliance iCT, Philips Healthcare) was used for CCT examination, with the patient in the supine position. The patients did not receive β-blockers to control the heart rate. The early phase scanning range was from the upper edge of the aortic arch to the diaphragmatic surface of the heart. The non-ionic contrast agent iohexol (350mgI/ml, 0.8 ml/kg) was injected through the antecubital vein at a flow rate of 4-5 ml/s, and then 30 ml of normal saline was injected at the same flow rate. CCT was performed with retrospective ECG gating, and the start of the image acquisition was determined using the bolus-triggering technique. A region of interest (ROI) was placed on the ascending aorta, and the image acquisition was started when the density in the ROI reached 130 Hounsfield units (approximately 10–15 s after contrast injection). The scanning parameters were as follows: tube voltage 120 kV, tube current 280–350 MAS, collimation 128 × 0.625 mm, pitch 0.18, rotation time 330 ms, and matrix 512 × 512.
      Delayed scanning covering the LAA area was automatically triggered at 50 s after the injection of the contrast agent. The tube voltage was 100 kV to reduce the scanning dose.
      At 45% and 75% of the cardiac phase, the early and delayed scanning images were reconstructed with a layer thickness of 0.9 mm and a section interval of 0.45 mm.

      2.3 Measurement of CCT parameters

      All images were processed and reviewed using a Philips EBW4.5 workstation. LAA early filling defects were defined as an obviously low-attenuation area, where the LAA cavity showed contrast enhancement less than that of the LA cavity, representing incomplete mixing of contrast medium and blood that appeared only in early phase images (Fig. 1). Multiplanar reconstruction (MPR) was used to obtain the cross-sectional image for measurement of the long diameter, short diameter and area of the LAA orifice, and the distance from the LAA orifice to the first bend of the LAA
      • Tian X.
      • Zhang X.J.
      • Yuan Y.F.
      • Li C.Y.
      • Zhou L.X.
      • Gao B.L.
      Morphological and functional parameters of left atrial appendage play a greater role in atrial fibrillation relapse after radiofrequency ablation.
      (Fig. 2). With the comprehensive cardiac analysis software built into the Philips EBW4.5 workstation, the LAA volume, morphology, depth of the LAA, and the first LAA bend were measured (Fig. 3). LAA morphology was based on the classification by Di Biase et al.
      • Di Biase L.
      • Santangeli P.
      • Anselmino M.
      • Mohanty P.
      • Salvetti I.
      • Gili S.
      • Horton R.
      • Sanchez J.E.
      • Bai R.
      • Mohanty S.
      • Pump A.
      • Cereceda Brantes M.
      • Gallinghouse G.J.
      • Burkhardt J.D.
      • Cesarani F.
      • Scaglione M.
      • Natale A.
      • Gaita F.
      Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study.
      : Cactus, Chicken Wing, Windsock, and Cauliflower (Fig. 4).
      Fig. 1
      Fig. 1Cardiac computed tomography (CCT) of an AF patient showed LAA filling defects on the early phase image (A) and no filling defect in the corresponding position on the delayed phase image(B).
      Fig. 2
      Fig. 2Measurement of the left atrial appendage (LAA) orifice and the distance from LAA orifice to the first bend of the LAA. A-D. The center of the cross positioning line is placed in the transition area between left atrium (LA) and LAA, and the two positioning lines are parallel and vertical to LAA length(A), respectively. On the LAA oblique coronal image, the cross positioning line is adjusted at the atrial wall fold in the oblique coronal image transition area, and the two positioning lines are made parallel and vertical to LAA (B) again to obtain LAA orifice image for measuring the long and short diameter (C) and the orifice area (D), and the distance from LAA orifice to the first bend is measured at the oblique coronal image (B).
      Fig. 3
      Fig. 3The volume, depth, angle of the first bend of LAA are measured by the cardiac function analysis software. A-D. The filling tool is used to fill the LAA on the axial image (A) and coronal image (B) to obtain the 3D image (C) of the LAA. The volume of LAA (C), LAA depth along the LAA direction and the angle of the first bend (D) are measured.
      Fig. 4
      Fig. 4LAA morphology. Chicken wing (A), cauliflower (B), cactus (C), and windsock (D).
      All parameters were analyzed by two experienced radiologists (with 8 and 2 years of experience, respectively) who reached a consensus for each examination.

      2.4 Statistical analysis

      Statistical analysis was performed using SPSS software (IBM, version 26.0, Chicago, IL, USA). Continuous variables were presented as mean ± standard deviation and tested with an independent t-test if the data followed a normal distribution or as median (interquartile range) and tested with the Mann-Whitney U test if the data had a skewed distribution. Categorical variables are presented as numbers or percentages and compared using the X2-test or Fisher's exact test. Multivariable logistical regression analysis was performed to identify risk factors for stroke. The predictors of stroke identified in the univariate analysis (P < 0.05) were entered as independent variables in multivariate models. P < 0.05 was considered to be statistically significant.

      3. Results

      3.1 Comparison of Clinical data and CCT variables between the previous stroke group and the non-stroke group in AF patients

      Compared with the non-stroke group, patients in the previous stroke group were older, had a lower ejection fraction, and had a lower BMI (P = 0.001, <0.001, and =0.036, respectively). The previous stroke group had a higher proportion of hypertension and diabetes mellitus than the non-stroke group (P = 0.01, =0.017, respectively). There were no significant differences between the two groups in terms of sex, type of AF, time since AF diagnosis, the prevalence of congestive heart failure, dyslipidemia, and coronary artery disease (P > 0.05). Further details concerning the comparison baseline of the characteristics between the groups are shown in Table 1.
      Table 1Baseline characteristics of patients in the non-stroke and previous stroke groups.
      VariablesNon-stroke (n = 89)Previous stroke (n = 63)P value
      Age (years)61.64 ± 11.1967.25 ± 8.120.001
      Male51 (57.30%)35 (55.56%)0.830
      Time since AF diagnosis (month)12 (3,60)24 (3,72)0.723
      Types of atrial fibrillation0.623
       Persistent36 (40.45%)28 (44.44%)
       Paroxysmal53 (59.55%)35 (55.56%)
       BMI (kg/cm2)26.62 ± 3.0025.49 ± 3.570.036
       Heart failure36 (40.45%)30 (47.62%)0.380
       Hypertension45 (50.56%)45 (71.43%)0.010
       Hyperlipidemia18 (20.22%)6 (9.52%)0.075
       Coronary heart disease49 (55.06%)36 (57.14%)0.799
       Diabetes16 (18.0%)22 (34.92%)0.017
       LVEF (%)64.4 (57.85,68.15)61.40 (57.30,67.00)0.000
      Note: AF, atrial fibrillation; CCT, cardiac computed tomography; BMI, body mass index; LAA, left atrial appendage. LVEF, left ventricular ejection fraction.
      The previous stroke group had a higher proportion of early LAA filling defects and a higher LAA volume index than the non-stroke group (P < 0.001, and P = 0.046, respectively). There were no significant differences between the two groups in the LAA orifice area, LAA orifice long diameter, LAA orifice short diameter, LAA morphology, distance from the LAA ostium to the first LAA bend, angle of the first LAA bend, LAA depth, or LAA volume (Table 2).
      Table 2Variables in CCT of AF patients in the non-stroke and previous stroke groups.
      VariablesNon stroke (n = 89)Previous stroke (n = 63)P value
      Early LAA filling defects16 (17.98%)28 (44.44%)0.000
      LAA orifice long diameter (mm)26.08 ± 5.6025.97 ± 5.660.903
      LAA orifice short diameter (mm)17.85 ± 4.5118.68 ± 4.280.259
      LAA orifice area (mm2)347.61 (266.44,445.98)398.50 (281.24,498.06)0.131
      Distance from LAA orifice to the first bend of the LAA (mm)5.5 (4.5,6.9)5.2 (4.2,6.9)0.400
      Angle of the first LAA bend114 (108,123)117 (110,127)0.074
      LAA depth (mm)42.1 (37.15,48.50)43.50 (38.70,47.90)0.557
      LAA volume (ml)8.46 ± 3.569.44 ± 4.180.119
      LAA volume index (ml/m2)4.42 (3.25,5.91)4.77 (3.71,6.70)0.046
      LAA morphology0.105
       Chicken wing24 (26.97%)7 (11.11%)
       Cauliflower36 (40.45%)34 (53.97%)
       Cactus16 (17.98%)13 (20.63%)
       Windsock13 (14.61%)9 (14.29%)
      Note: AF, atrial fibrillation; CCT, cardiac computed tomography; BMI, body mass index; LAA, left atrial appendage. LVEF, left ventricular ejection fraction.

      3.2 Multivariable logistic regression analysis for potential risk factors of stroke in AF patients

      The stroke related factors (P < 0.05) determined in the univariate analysis were included in the multivariate logistic regression model as independent variables (age, BMI, hypertension, diabetes, left ventricular ejection fraction, LAA early filling defect, and LAA volume index). After adjusting for these factors, the LAA early filling defect was still an important risk factor for stroke, and the LAA volume index had no significant correlation with ischemic stroke history (Table 3).
      Table 3Multivariable logistic regression analysis for potential risk factors of stroke in AF patients.
      VariablesOR95%CIP value
      Age (years)1.0671.024–1.1110.002
      BMI (kg/cm2)0.8570.756–0.9730.051
      Hypertension2.7621.189–6.4170.053
      Diabetes2.8501.251–6.4940.013
      LVEF (%)0.9960.955–1.0380.949
      LAA volume index (ml/m2)1.1060.910–1.3450.485
      Early LAA filling defects4.3391.951–9.6530.000
      Note: BMI, body mass index; LAA, left atrial appendage. LVEF, left ventricular ejection fraction; OR, odds ratio; CI, confidence interval.
      Comparison of Clinical data and CCT variables between the early-phase filling defects with stroke group and the early-phase filling defects without stroke group.
      The clinical characteristics and CCT variables were not significantly different between the two groups (Tables 4 and 5), respectively.
      Table 4Baseline characteristics in patients with early-phase filling defects with or without stroke.
      VariablesEarly-phase filling defects without stroke (n = 16)Early-phase filling defects with stroke (n = 28)P value
      Age (years)61.00 ± 10.2566.71 ± 8.520.054
      Male9 (56.2%)15 (53.6%)0.864
      Time since AF diagnosis (month)18 (6,75)18 (4.5,72)0.971
      Types of atrial fibrillation0.798
       Persistent12 (75.0%)20 (71.4%)
       Paroxysmal4 (25.0%)8 (28.6%)
       BMI (kg/m2)26.71 ± 2.2625.84 ± 4.130.368
       Heart failure10 (62.5%)19 (67.9%)0.718
       Hypertension6 (37.5%)19 (67.9%)0.051
       Hyperlipidemia4 (25.0%)2 (7.1%)0.169
       Coronary heart disease8 (50%)17 (60.7%)0.490
       Diabetes3 (18.8%)7 (25%)0.724
       LVEF (%)n60.6 (53.35,65.88)0.311
      Note: AF, atrial fibrillation; BMI, body mass index; LAA, left atrial appendage. LVEF, left ventricular ejection fraction.
      Table 5Comparison of CCT variables in patients of early-phase filling defects with or without stroke.
      VariablesEarly-phase filling defects without stroke (n = 16)Early-phase filling defects with stroke (n = 28)P value
      LAA orifice long diameter (mm)28.8 (22.65,32.25)27.8 (25.8,30.68)0.760
      LAA orifice short diameter (mm)21.63 ± 5.4520.75 ± 3.200.560
      LAA orifice area (mm2)492.31 ± 230.12463.47 ± 117.430.645
      Distance from LAA orifice to the first bend of the LAA (mm)6 (4.4,8.1)5.1 (4.1,7.0)0.187
      Angle of the first LAA bend115.5 (110.25,123.75)119.5 (110.5,129.0)0.288
      LAA depth (mm)45.34 ± 9.8746.32 ± 9.080.741
      LAA volume (ml)10.85 (7.05,13.23)11.55 (8.35,13.3)0.472
      LAA volume index (ml/m2)5.79 (4.23,7.37)6.41 (4.62,7.38)0.380
      LAA morphology0.952
       Chicken wing3 (18.8%)4 (14.3%)
       Cauliflower9 (56.2%)16 (57.1%)
       Cactus2 (12.5%)3 (10.7%)
       Windsock2 (12.5%)5 (17.9%)

      4. Discussion

      In this study, after adjusting for confounding factors, the early filling defect of the LAA was still significantly related to the history of ischemic stroke, which is similar to the study by Inoue.
      • Inoue T.
      • Suematsu Y.
      Poor enhancement pattern of left atrial appendage in cardiac computed tomography is associated with stroke in persistent atrial fibrillation patients.
      This finding provides a new reference for the risk stratification of stroke in patients with AF.
      Early-phase filling defects in the LAA on CCT images show that blood and contrast agents are mixed unevenly. This was a sign of blood stasis. According to Virchow's triad for thrombogenesis,
      • Watson T.
      • Shantsila E.
      • Lip G.Y.
      Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited.
      which consists of endothelial dysfunction, abnormal blood stasis, and a hypercoagulable state, early-phase filling defects in LAA are associated with thrombogenesis, which increases the risk of stroke. Ouchi
      • Ouchi K.
      • Sakuma T.
      • Higuchi T.
      • Yoshida J.
      • Narui R.
      • Nojiri A.
      • Yamane T.
      • Ojiri H.
      Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
      reported that persistent AF, decreased LAAFV, increased LAA volume index, and decreased LVEF correlated with early phase fill defects in the LAA, indicating that hemodynamics were related to early phase fill defects. Some of these factors, such as decreased LAAFV
      • Takada T.
      • Yasaka M.
      • Nagatsuka K.
      • Minematsu K.
      • Yamaguchi T.
      Blood flow in the left atrial appendage and embolic stroke in nonvalvular atrial fibrillation.
      and increased LAA volume
      • Burrell L.D.
      • Horne B.D.
      • Anderson J.L.
      • Muhlestein J.B.
      • Whisenant B.K.
      Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation.
      were previously shown to be risk factors for stroke. Thus, the early phase filling defect in the LAA is a vital sign for assessing stroke risk in patients with AF. In a study by Inoue et al.,
      • Inoue T.
      • Suematsu Y.
      Poor enhancement pattern of left atrial appendage in cardiac computed tomography is associated with stroke in persistent atrial fibrillation patients.
      the early phase LAA enhancement pattern was defined as a poor, intermediate, or good enhancement pattern, based on CCT images of 147 patients with chronic AF. They observed a poor enhancement pattern related to stroke. Our study was based on a group of participants including patients with chronic AF but also paroxysmal AF patients. In addition, we simplified the enhancement pattern to good or bad (filling well or filling defects), which made it easier for physicians to use.
      Whether the morphologic parameters of LAA are related to stroke risk has been discussed for a long time, including the morphology of LAA. In our study, the results showed that there was no significant difference in LAA morphology between the previous stroke group and non-stroke groups in AF patients. This may be because the morphology of LAA is extremely complex and heterogeneous. Di Biase et al.
      • Di Biase L.
      • Santangeli P.
      • Anselmino M.
      • Mohanty P.
      • Salvetti I.
      • Gili S.
      • Horton R.
      • Sanchez J.E.
      • Bai R.
      • Mohanty S.
      • Pump A.
      • Cereceda Brantes M.
      • Gallinghouse G.J.
      • Burkhardt J.D.
      • Cesarani F.
      • Scaglione M.
      • Natale A.
      • Gaita F.
      Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study.
      reported four different LAA morphologies (Cactus, Chicken-Wing, Windsock, and Cauliflower) and found that the non-Chicken-Wing morphology is associated with a 3-fold risk of prior thromboembolic events. And many researches also provided similar results.
      • Lee J.M.
      • Seo J.
      • Uhm J.S.
      • Kim Y.J.
      • Lee H.J.
      • Kim J.Y.
      • Sung J.H.
      • Pak H.N.
      • Lee M.H.
      • Joung B.
      Why is left atrial appendage morphology related to Strokes? An analysis of the flow velocity and orifice size of the left atrial appendage.
      • Kong B.
      • Liu Y.
      • Hu H.
      • Wang L.
      • Fan Y.
      • Mei Y.
      • Liu W.
      • Liao J.
      • Liu D.
      • Xing D.
      • Huang H.
      Left atrial appendage morphology in patients with atrial fibrillation in China: implications for stroke risk assessment from a single center study.
      • Petersen M.
      • Roehrich A.
      • Balzer J.
      • Shin D.I.
      • Meyer C.
      • Kelm M.
      • Kehmeier E.S.
      Left atrial appendage morphology is closely associated with specific echocardiographic flow pattern in patients with atrial fibrillation.
      However, the relationship between the morphology of LAA and stroke is still controversal.
      • Ren J.F.
      • Callans D.J.
      • Marchlinski F.E.
      What is the natural relationship between left atrial appendage morphology and history of stroke?.
      A previous study by Adukauskaite A. reported that only the windsock LAA type was independently associated with CE stroke in the presence of AF.
      • Adukauskaite A.
      • Barbieri F.
      • Senoner T.
      • Plank F.
      • Knoflach M.
      • Boehme C.
      • Hintringer F.
      • Mueller S.
      • Bauer A.
      • Feuchtner G.
      • Dichtl W.
      Left atrial appendage morphology and left Atrial Wall thickness are associated with cardio-embolic stroke.
      In addition, some studies have reported that LAA morphologies are unrelated to stroke risk in the AF population.
      • Lee J.M.
      • Shim J.
      • Uhm J.S.
      • Kim Y.J.
      • Lee H.J.
      • Pak H.N.
      • Lee M.H.
      • Joung B.
      Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation.
      • Khurram I.M.
      • Dewire J.
      • Mager M.
      • Maqbool F.
      • Zimmerman S.L.
      • Zipunnikov V.
      • Beinart R.
      • Marine J.E.
      • Spragg D.D.
      • Berger R.D.
      • Ashikaga H.
      • Nazarian S.
      • Calkins H.
      Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation.
      • Kimura T.
      • Takatsuki S.
      • Inagawa K.
      • Katsumata Y.
      • Nishiyama T.
      • Nishiyama N.
      • Fukumoto K.
      • Aizawa Y.
      • Tanimoto Y.
      • Tanimoto K.
      • Jinzaki M.
      • Fukuda K.
      Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores.
      • Nedios S.
      • Koutalas E.
      • Kornej J.
      • Rolf S.
      • Arya A.
      • Sommer P.
      • Husser D.
      • Hindricks G.
      • Bollmann A.
      Cardiogenic stroke despite low CHA2 DS2 -VASc score: assessing stroke risk by left atrial appendage anatomy (ASK LAA).
      • Fukushima K.
      • Fukushima N.
      • Kato K.
      • Ejima K.
      • Sato H.
      • Fukushima K.
      • Saito C.
      • Hayashi K.
      • Arai K.
      • Manaka T.
      • Ashihara K.
      • Shoda M.
      • Hagiwara N.
      Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation.
      The different results of these studies are probably due to intra-observer variability,
      • Wu L.
      • Liang E.
      • Fan S.
      • Zheng L.
      • Du Z.
      • Liu S.
      • Hu F.
      • Fan X.
      • Chen G.
      • Ding L.
      • Yao Y.
      Relation of left atrial appendage morphology determined by computed tomography to prior stroke or to increased risk of stroke in patients with atrial fibrillation.
      sampling error, or race variaty.
      • Ono S.
      • Kubo S.
      • Maruo T.
      • Kar S.
      • Kadota K.
      Left atrial appendage size in patients with atrial fibrillation in Japan and the United States.
      The different results also lie in the roles of the LAA orifice and volume in stroke. Previous studies have shown that increased LAA orifice area, depth, and volume are associated with an increased risk of stroke in AF.
      • Burrell L.D.
      • Horne B.D.
      • Anderson J.L.
      • Muhlestein J.B.
      • Whisenant B.K.
      Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation.
      • Lee J.M.
      • Seo J.
      • Uhm J.S.
      • Kim Y.J.
      • Lee H.J.
      • Kim J.Y.
      • Sung J.H.
      • Pak H.N.
      • Lee M.H.
      • Joung B.
      Why is left atrial appendage morphology related to Strokes? An analysis of the flow velocity and orifice size of the left atrial appendage.
      • Fukushima K.
      • Fukushima N.
      • Kato K.
      • Ejima K.
      • Sato H.
      • Fukushima K.
      • Saito C.
      • Hayashi K.
      • Arai K.
      • Manaka T.
      • Ashihara K.
      • Shoda M.
      • Hagiwara N.
      Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation.
      • Lee J.M.
      • Kim J.B.
      • Uhm J.S.
      • Pak H.N.
      • Lee M.H.
      • Joung B.
      Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA2DS2-VASc scores.
      However, these findings were controversial.
      • Anselmino M.
      • Scaglione M.
      • Di Biase L.
      • Gili S.
      • Santangeli P.
      • Corsinovi L.
      • Pianelli M.
      • Cesarani F.
      • Faletti R.
      • Righi D.
      • Natale A.
      • Gaita F.
      Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation.
      • Dudzinska-Szczerba K.
      • Michalowska I.
      • Piotrowski R.
      • Sikorska A.
      • Paszkowska A.
      • Stachnio U.
      • Kowalik I.
      • Kulakowski P.
      • Baran J.
      Assessment of the left atrial appendage morphology in patients after ischemic stroke - the ASSAM study.
      In our study, there was no significant difference in LAA orifice area, long diameter and angle of the first LAA bend between the previous stroke group and the no stroke group, which was similar with the results of Katarzyna et al.
      • Dudzinska-Szczerba K.
      • Michalowska I.
      • Piotrowski R.
      • Sikorska A.
      • Paszkowska A.
      • Stachnio U.
      • Kowalik I.
      • Kulakowski P.
      • Baran J.
      Assessment of the left atrial appendage morphology in patients after ischemic stroke - the ASSAM study.
      But our study showed that the distance from LAA ostium to the first bend of the LAA did not associate with stroke risk, which was different with them. Further investigation based on a larger group of participants is required. In this study, the volume index of the LAA in the previous stroke group was significantly higher than that in the non-stroke group on univariate analysis. In further multivariate logistic regression analysis, the volume index of LAA was not an independent risk factor for stroke, which may be caused by the correlation between the early filling defects of LAA and the volume of LAA.
      • Ouchi K.
      • Sakuma T.
      • Higuchi T.
      • Yoshida J.
      • Narui R.
      • Nojiri A.
      • Yamane T.
      • Ojiri H.
      Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
      In addition, the study further divided the patients with LAA filling defects into two groups according to the history of ischemic stroke. It was found that there were no differences in left atrial appendage morphological indexes between the two groups, which indicated that stroke was not related to LAA morphology in patients with left atrial appendage filling defects.
      The CHA2DS2-VASc score is widely used to stratify stroke risk in patients with the purpose to initiate anticoagulation therapy. It focuses mostly on well-known risk factors for ischemic stroke, and none of these factors assess the LAA itself, where most of the thrombi in AF are formed. The 2016 ESC guideline suggests that patients with a CHA2DS2-VASc score ≥ 1 would better choose anticoagulation treatment to reduce stroke risk.
      • Kirchhof P.
      • Benussi S.
      • Kotecha D.
      • Ahlsson A.
      • Atar D.
      • Casadei B.
      • Castella M.
      • Diener H.C.
      • Heidbuchel H.
      • Hendriks J.
      • Hindricks G.
      • Manolis A.S.
      • Oldgren J.
      • Popescu B.A.
      • Schotten U.
      • Van Putte B.
      • Vardas P.
      • Agewall S.
      • Camm J.
      • Baron Esquivias G.
      • Budts W.
      • Carerj S.
      • Casselman F.
      • Coca A.
      • De Caterina R.
      • Deftereos S.
      • Dobrev D.
      • Ferro J.M.
      • Filippatos G.
      • Fitzsimons D.
      • Gorenek B.
      • Guenoun M.
      • Hohnloser S.H.
      • Kolh P.
      • Lip G.Y.
      • Manolis A.
      • McMurray J.
      • Ponikowski P.
      • Rosenhek R.
      • Ruschitzka F.
      • Savelieva I.
      • Sharma S.
      • Suwalski P.
      • Tamargo J.L.
      • Taylor C.J.
      • Van Gelder I.C.
      • Voors A.A.
      • Windecker S.
      • Zamorano J.L.
      • Zeppenfeld K.
      2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
      However, Gage et al. found that non-valvular AF patients with a CHA2DS2-VASc score of 0 still have a stroke risk of 1.9%.
      • Gage B.F.
      • Waterman A.D.
      • Shannon W.
      • Boechler M.
      • Rich M.W.
      • Radford M.J.
      Validation of clinical classification schemes for predicting stroke: results from the National Registry of atrial fibrillation.
      These findings suggest that simple stratification using the CHA2DS2-VASc score is insufficient.
      The finding that the early filling defect of the LAA is significantly related to the history of ischemic stroke, is very helpful for patients with atrial fibrillation with a CHA2DS2-VASc score ≤ 1, because these patients are usually considered to be a low-risk group for stroke and neglect prevention, but the presence of LAA early filling defect is associated with a higher risk of thromboembolism. According to our research results, it is also necessary for these patients to use anticoagulant drugs promptly to prevent stroke. However, anticoagulant therapy requires comprehensive clinical evaluation of the patient's condition to prevent the risk of bleeding.
      There are some limitations to this study: (1) This study is a retrospective study, which cannot guarantee that all patients in the stroke group suffer from cardiogenic stroke, nor can it be sure that the left atrial appendage hemodynamics of patients at the time of stroke; (2) This study was a single-center, small-sample study, which may have selection bias. The subjects included in the study were non valvular atrial fibrillation patients who planned to undergo radio-frequency ablation or LAA occlusion, and most of them were AF patients with poor drug treatment effects. Therefore, the conclusion of this study may not be applicable to all atrial fibrillation populations; (3) The filling of the LAA contrast agent is related to the iodine concentration in the contrast agent, the injection rate and the amount of contrast agent. Therefore, the repeatability of this study may be reduced owing to the influence of the scanning scheme and the equipment performance. Our research results need to be verified in a large sample of prospective studies.

      5. Conclusion

      AF patients with LAA non-thrombotic filling defects in the early phase of CCT had an increased risk of ischemic stroke compared to those without filling defects. This finding may help optimize stroke risk stratification in patients with AF.

      CRediT authorship contribution statement

      Xiao-Wei Liu: Data curation, Formal analysis, Writing – original draft, Writing – review & editing. Li-qun Yan: Investigation. Guo-shi Wang: Methodology. Yu-han Sun: Data curation. Wen-jun Bao: Formal analysis. Hao-wen Zhang: Resources. Lan Yang: Software. Chen Chen: Validation. Meng-Ya Li: Visualization. Lei Yang: Visualization. Xu-Qian Zhang: Validation. Xin Tian: Investigation, Writing – original draft, Writing – review & editing. Cai-Ying Li: Conceptualization, Project administration, Supervision.

      References

        • Benjamin E.J.
        • Blaha M.J.
        • Chiuve S.E.
        • Cushman M.
        • Das S.R.
        • Deo R.
        • de Ferranti S.D.
        • Floyd J.
        • Fornage M.
        • Gillespie C.
        • Isasi C.R.
        • Jimenez M.C.
        • Jordan L.C.
        • Judd S.E.
        • Lackland D.
        • Lichtman J.H.
        • Lisabeth L.
        • Liu S.
        • Longenecker C.T.
        • Mackey R.H.
        • Matsushita K.
        • Mozaffarian D.
        • Mussolino M.E.
        • Nasir K.
        • Neumar R.W.
        • Palaniappan L.
        • Pandey D.K.
        • Thiagarajan R.R.
        • Reeves M.J.
        • Ritchey M.
        • Rodriguez C.J.
        • Roth G.A.
        • Rosamond W.D.
        • Sasson C.
        • Towfighi A.
        • Tsao C.W.
        • Turner M.B.
        • Virani S.S.
        • Voeks J.H.
        • Willey J.Z.
        • Wilkins J.T.
        • Wu J.H.
        • Alger H.M.
        • Wong S.S.
        • Muntner P.
        • American Heart Association Statistics C
        • Stroke Statistics S
        Heart disease and stroke statistics-2017 update: a report from the American Heart Association.
        Circulation. 2017; 135: e146-e603
        • Van den Ham H.A.
        • Klungel O.H.
        • Singer D.E.
        • Leufkens H.G.
        • van Staa T.P.
        Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a National Primary Care Database.
        J Am Coll Cardiol. 2015; 66: 1851-1859
        • Inoue T.
        • Suematsu Y.
        Poor enhancement pattern of left atrial appendage in cardiac computed tomography is associated with stroke in persistent atrial fibrillation patients.
        J Thorac Dis. 2019; 11: 3315-3324
        • Tian X.
        • Zhang X.J.
        • Yuan Y.F.
        • Li C.Y.
        • Zhou L.X.
        • Gao B.L.
        Morphological and functional parameters of left atrial appendage play a greater role in atrial fibrillation relapse after radiofrequency ablation.
        Sci Rep. 2020; 10: 8072
        • Di Biase L.
        • Santangeli P.
        • Anselmino M.
        • Mohanty P.
        • Salvetti I.
        • Gili S.
        • Horton R.
        • Sanchez J.E.
        • Bai R.
        • Mohanty S.
        • Pump A.
        • Cereceda Brantes M.
        • Gallinghouse G.J.
        • Burkhardt J.D.
        • Cesarani F.
        • Scaglione M.
        • Natale A.
        • Gaita F.
        Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study.
        J Am Coll Cardiol. 2012; 60: 531-538
        • Watson T.
        • Shantsila E.
        • Lip G.Y.
        Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited.
        Lancet. 2009; 373: 155-166
        • Ouchi K.
        • Sakuma T.
        • Higuchi T.
        • Yoshida J.
        • Narui R.
        • Nojiri A.
        • Yamane T.
        • Ojiri H.
        Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
        J Cardiol. 2022; 79: 211-218
        • Takada T.
        • Yasaka M.
        • Nagatsuka K.
        • Minematsu K.
        • Yamaguchi T.
        Blood flow in the left atrial appendage and embolic stroke in nonvalvular atrial fibrillation.
        Eur Neurol. 2001; 46: 148-152
        • Burrell L.D.
        • Horne B.D.
        • Anderson J.L.
        • Muhlestein J.B.
        • Whisenant B.K.
        Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation.
        Am J Cardiol. 2013; 112: 1148-1152
        • Lee J.M.
        • Seo J.
        • Uhm J.S.
        • Kim Y.J.
        • Lee H.J.
        • Kim J.Y.
        • Sung J.H.
        • Pak H.N.
        • Lee M.H.
        • Joung B.
        Why is left atrial appendage morphology related to Strokes? An analysis of the flow velocity and orifice size of the left atrial appendage.
        J Cardiovasc Electrophysiol. 2015; 26: 922-927
        • Kong B.
        • Liu Y.
        • Hu H.
        • Wang L.
        • Fan Y.
        • Mei Y.
        • Liu W.
        • Liao J.
        • Liu D.
        • Xing D.
        • Huang H.
        Left atrial appendage morphology in patients with atrial fibrillation in China: implications for stroke risk assessment from a single center study.
        Chin Med J (Engl). 2014; 127: 4210-4214
        • Petersen M.
        • Roehrich A.
        • Balzer J.
        • Shin D.I.
        • Meyer C.
        • Kelm M.
        • Kehmeier E.S.
        Left atrial appendage morphology is closely associated with specific echocardiographic flow pattern in patients with atrial fibrillation.
        Europace. 2015; 17: 539-545
        • Ren J.F.
        • Callans D.J.
        • Marchlinski F.E.
        What is the natural relationship between left atrial appendage morphology and history of stroke?.
        J Am Coll Cardiol. 2013; 61: 689-690
        • Adukauskaite A.
        • Barbieri F.
        • Senoner T.
        • Plank F.
        • Knoflach M.
        • Boehme C.
        • Hintringer F.
        • Mueller S.
        • Bauer A.
        • Feuchtner G.
        • Dichtl W.
        Left atrial appendage morphology and left Atrial Wall thickness are associated with cardio-embolic stroke.
        J Clin Med. 2020; 9: 3944
        • Lee J.M.
        • Shim J.
        • Uhm J.S.
        • Kim Y.J.
        • Lee H.J.
        • Pak H.N.
        • Lee M.H.
        • Joung B.
        Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation.
        Am J Cardiol. 2014; 113: 963-969
        • Khurram I.M.
        • Dewire J.
        • Mager M.
        • Maqbool F.
        • Zimmerman S.L.
        • Zipunnikov V.
        • Beinart R.
        • Marine J.E.
        • Spragg D.D.
        • Berger R.D.
        • Ashikaga H.
        • Nazarian S.
        • Calkins H.
        Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation.
        Heart Rhythm. 2013; 10: 1843-1849
        • Kimura T.
        • Takatsuki S.
        • Inagawa K.
        • Katsumata Y.
        • Nishiyama T.
        • Nishiyama N.
        • Fukumoto K.
        • Aizawa Y.
        • Tanimoto Y.
        • Tanimoto K.
        • Jinzaki M.
        • Fukuda K.
        Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores.
        Heart Rhythm. 2013; 10: 921-925
        • Nedios S.
        • Koutalas E.
        • Kornej J.
        • Rolf S.
        • Arya A.
        • Sommer P.
        • Husser D.
        • Hindricks G.
        • Bollmann A.
        Cardiogenic stroke despite low CHA2 DS2 -VASc score: assessing stroke risk by left atrial appendage anatomy (ASK LAA).
        J Cardiovasc Electrophysiol. 2015; 26: 915-921
        • Fukushima K.
        • Fukushima N.
        • Kato K.
        • Ejima K.
        • Sato H.
        • Fukushima K.
        • Saito C.
        • Hayashi K.
        • Arai K.
        • Manaka T.
        • Ashihara K.
        • Shoda M.
        • Hagiwara N.
        Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation.
        Eur Heart J Cardiovasc Imaging. 2016; 17: 59-66
        • Wu L.
        • Liang E.
        • Fan S.
        • Zheng L.
        • Du Z.
        • Liu S.
        • Hu F.
        • Fan X.
        • Chen G.
        • Ding L.
        • Yao Y.
        Relation of left atrial appendage morphology determined by computed tomography to prior stroke or to increased risk of stroke in patients with atrial fibrillation.
        Am J Cardiol. 2019; 123: 1283-1286
        • Ono S.
        • Kubo S.
        • Maruo T.
        • Kar S.
        • Kadota K.
        Left atrial appendage size in patients with atrial fibrillation in Japan and the United States.
        Heart Vessels. 2021; 36: 277-284
        • Lee J.M.
        • Kim J.B.
        • Uhm J.S.
        • Pak H.N.
        • Lee M.H.
        • Joung B.
        Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA2DS2-VASc scores.
        Heart Rhythm. 2017; 14: 1297-1301
        • Anselmino M.
        • Scaglione M.
        • Di Biase L.
        • Gili S.
        • Santangeli P.
        • Corsinovi L.
        • Pianelli M.
        • Cesarani F.
        • Faletti R.
        • Righi D.
        • Natale A.
        • Gaita F.
        Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation.
        Heart Rhythm. 2014; 11: 2-7
        • Dudzinska-Szczerba K.
        • Michalowska I.
        • Piotrowski R.
        • Sikorska A.
        • Paszkowska A.
        • Stachnio U.
        • Kowalik I.
        • Kulakowski P.
        • Baran J.
        Assessment of the left atrial appendage morphology in patients after ischemic stroke - the ASSAM study.
        Int J Cardiol. 2021; 330: 65-72
        • Kirchhof P.
        • Benussi S.
        • Kotecha D.
        • Ahlsson A.
        • Atar D.
        • Casadei B.
        • Castella M.
        • Diener H.C.
        • Heidbuchel H.
        • Hendriks J.
        • Hindricks G.
        • Manolis A.S.
        • Oldgren J.
        • Popescu B.A.
        • Schotten U.
        • Van Putte B.
        • Vardas P.
        • Agewall S.
        • Camm J.
        • Baron Esquivias G.
        • Budts W.
        • Carerj S.
        • Casselman F.
        • Coca A.
        • De Caterina R.
        • Deftereos S.
        • Dobrev D.
        • Ferro J.M.
        • Filippatos G.
        • Fitzsimons D.
        • Gorenek B.
        • Guenoun M.
        • Hohnloser S.H.
        • Kolh P.
        • Lip G.Y.
        • Manolis A.
        • McMurray J.
        • Ponikowski P.
        • Rosenhek R.
        • Ruschitzka F.
        • Savelieva I.
        • Sharma S.
        • Suwalski P.
        • Tamargo J.L.
        • Taylor C.J.
        • Van Gelder I.C.
        • Voors A.A.
        • Windecker S.
        • Zamorano J.L.
        • Zeppenfeld K.
        2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
        Europace. 2016; 18: 1609-1678
        • Gage B.F.
        • Waterman A.D.
        • Shannon W.
        • Boechler M.
        • Rich M.W.
        • Radford M.J.
        Validation of clinical classification schemes for predicting stroke: results from the National Registry of atrial fibrillation.
        JAMA. 2001; 285: 2864-2870